Showing 51-60 of 8172 results for "".
Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/annual-trends-in-medicare-part-d-prescription-claims-for-guselkumab-20182020/28861/Jachin Wu, MD, FAAD, and colleagues talk about Medicare claims for guselkumabNew Drugs for Treating Fungal Infections
https://practicaldermatology.com/topics/general-topics/new-drugs-for-treating-fungal-infections/21426/A review of recent developments for efficacious treatment.Critical Factors to Advancing Melanoma Diagnosis and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/critical-factors-to-advancing-melanoma-diagnosis-and-treatment/22970/Dermatologists need to stay abreast of technologies for evaluation of lesions and ensure that medical oncologists within their referral network recognize the importance of clinical trials.Lashing Out: A New Direction in Lash Treatment
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/lashing-out-a-new-direction-in-lash-treatment/20743/New eyelash ptosis treatment means no more lash curlers.Pre-Treating Resectable Melanomas with PD-1 Inhibitors: An Emerging Strategy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pre-treating-resectable-melanomas-with-pd-1-inhibitors-an-emerging-strategy/20489/Pre-treatment with anti-PD1 agents may improve outcomes for some patients and provide prognostic clues.Advanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-management-solutions-for-high-grade-cutaneous-toxicities-to-cancer-therapy/57176/The emergence of immune checkpoint inhibitors (ICIs) has fundamentally altered the prognosis for patients with advanced skin malignancies, yet the high incidence of cutaneous immune-related adverse events (irAEs) remains a significant barrier to treatment continuity. Here, we review the clinical manMycosis Fungoides: Practical Tips on Specific Therapies
https://practicaldermatology.com/topics/general-topics/mycosis-fungoides-practical-tips-on-specific-therapies/21973/With common sense and knowledge of the therapy being administered, the dermatologist can effectively and safely treat MF patients.Complications of Biologic Therapy for Psoriasis: Part II
https://practicaldermatology.com/topics/psoriasis/complications-of-biologic-therapy-for-psoriasis-part-ii/22039/Therapeutic success requires clinicians to understand emerging and established safety concerns.Evaluating the Interleukin Antibodies and Their Future in Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0809_13-php/22791/New investigational therapies blocking IL-12/23 may offer new possibilities in the treatment of psoriatic disease.